文献(201-300)

201. Domanski M, Tian X, Haigney M, et al. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail

2006; 12: 327-332. PMID: 16762792

202. Masuyama T, Tsujino T, Origasa H, et al. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.

Circ J 2012; 76: 833-842. PMID: 22451450

203. Gheorghiade M, Konstam MA, Burnett JC, et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan

(EVEREST) Investigators. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure:

the EVEREST Clinical Status Trials. JAMA 2007; 297: 1332-1343. PMID: 17384438

204. Konstam MA, Gheorghiade M, Burnett JC, et al. Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan

(EVEREST) Investigators. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

JAMA 2007; 297: 1319-1331. PMID: 17384437

205. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Vet

erans Administration Cooperative Study. N Engl J Med 1986; 314: 1547-1552. PMID: 3520315

206. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive

heart failure. N Engl J Med 1991; 325: 303-310. PMID: 2057035

207. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336:

525-533. PMID: 9036306

208. Packer M, Carver JR, Rodeheffer RJ, et al. PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic

heart failure. N Engl J Med 1991; 325: 1468-1475. PMID: 1944425

209. Cohn JN, Goldstein SO, Greenberg BH, et al. Vesnarinone Trial Investigators. A dose-dependent increase in mortality with vesnarinone

among patients with severe heart failure. N Engl J Med 1998; 339: 1810-1816. PMID: 9854116

210. Davis BR, Cutler JA, Furberg CD, et al. ALLHAT Collaborative Research Group. Relationship of antihypertensive treatment regimens

and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further

analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Ann Intern Med 2002; 137: 313-320.

PMID: 12204014

211. Cleland JG, Tendera M, Adamus J, et al. PEP-CHF Investigators. The perindopril in elderly people with chronic heart failure (PEP-CHF)

study. Eur Heart J 2006; 27: 2338-2345. PMID: 16963472

212. Yusuf S, Pfeffer MA, Swedberg K, et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart

failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362: 777-781. PMID: 13678871

213. Massie BM, Carson PE, McMurray JJ, et al. I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection

fraction. N Engl J Med 2008; 359: 2456-2467. PMID: 19001508

214. Yamamoto K, Origasa H, Hori M, et al. J-DHF Investigators. Effects of carvedilol on heart failure with preserved ejection fraction: the

Japanese Diastolic Heart Failure Study (J-DHF). Eur J Heart Fail 2013; 15: 110-118. PMID: 22983988

215. Pitt B, Pfeffer MA, Assmann SF, et al. TOPCAT Investigators. Spironolactone for heart failure with preserved ejection fraction. N Engl

J Med 2014; 370: 1383-1392. PMID: 24716680

216. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation

group trial. Circulation 2006; 114: 397-403. PMID: 16864724

217. Lund LH, Benson L, Dahlström U, et al. Association between use of renin-angiotensin system antagonists and mortality in patients with

heart failure and preserved ejection fraction. JAMA 2012; 308: 2108- 2117. PMID: 23188027

218. Liu F, Chen Y, Feng X, et al. Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis. PLoS One 2014; 9:

e90555. PMID: 24599093

219. Lund LH, Benson L, Dahlström U, et al. Association between use of β-blockers and outcomes in patients with heart failure and preserved

ejection fraction. JAMA 2014; 312: 2008-2018. PMID: 25399276

220. Redfield MM, Anstrom KJ, Levine JA, et al. NHLBI Heart Failure Clinical Research Network. Isosorbide Mononitrate in Heart Failure

with Preserved Ejection Fraction. N Engl J Med 2015; 373: 2314- 2324. PMID: 26549714

221. Lim SL, Benson L, Dahlström U, et al. Association Between Use of Long-Acting Nitrates and Outcomes in Heart Failure With Preserved

Ejection Fraction. Circ Heart Fail 2017; 10: e003534. PMID:28377439

222. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable

defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583. PMID: 9411221

223. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients

resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation 2000; 102: 748-754. PMID: 10942742

224. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter

defibrillator against amiodarone. Circulation 2000; 101: 1297-1302. PMID: 10725290

225. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.

AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable

Defibrillator Study. Eur Heart J 2000; 21: 2071-2078. PMID:11102258

226. Russo AM, Stainback RF, Bailey SR, et al. ACCF/HRS/AHA/ASE/ HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable

cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate

use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society

of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and

Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 2013; 61: 1318-1368. PMID: 23453819

227. Zipes DP, Camm AJ, Borggrefe M, et al. European Heart Rhythm Association. ACC/AHA/ESC 2006 guidelines for management of patients

with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American

Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop

Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll

Cardiol 2006; 48: e247-e346. PMID: 16949478

228. Kuck KH, Schaumann A, Eckardt L, et al. VTACH study group. Catheter ablation of stable ventricular tachycardia before defibrillator

implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 2010; 375: 31-40.

PMID: 20109864

229. Moss AJ, Hall WJ, Cannom DS, et al. Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an

implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940.

PMID: 8960472

230. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a

defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883. PMID: 11907286

231. Buxton AE, Lee KL, Fisher JD, et al. Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of

sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-1890. PMID: 10601507

232. Hohnloser SH, Kuck KH, Dorian P, et al. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after

acute myocardial infarction. N Engl J Med 2004; 351: 2481-2488. PMID: 15590950

233. Kadish A, Dyer A, Daubert JP, et al. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158. PMID:

15152060

234. Bardy GH, Lee KL, Mark DB, et al. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable

cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237. PMID: 15659722

235. Bänsch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy

Trial (CAT). Circulation 2002; 105: 1453-1458. PMID: 11914254

236. Strickberger SA, Hummel JD, Bartlett TG, et al. AMIOVIRT Investigators. Amiodarone versus implantable cardioverter-

defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--

AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707-1712. PMID: 12767651

237. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION)

Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J

Med 2004; 350: 2140-2150. PMID: 15152059

238. Køber L, Thune JJ, Nielsen JC, et al. DANISH Investigators. Defibrillator Implantation in Patients with Nonischemic Systolic Heart

Failure. N Engl J Med 2016; 375: 1221-1230. PMID: 27571011

239. Shiba N, Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag 2008; 4: 103-113.

PMID: 18629369

240. Cazeau S, Leclercq C, Lavergne T, et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite

biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880. PMID:

11259720

241. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med

2002; 346: 1845-1853. PMID: 12063368

242. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients

with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780- 1787. PMID: 12419298

243. Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect

of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am

Coll Cardiol 2002; 39: 2026-2033. PMID: 12084604

244. Young JB, Abraham WT, Smith AL, et al. Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE

ICD Trial. JAMA 2003; 289: 2685-2694. PMID: 12771115

245. Higgins SL, Hummel JD, Niazi IK, et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular

conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42: 1454-1459. PMID: 14563591

246. Abraham WT, Young JB, León AR, et al. Multicenter InSync ICD II Study Group. Effects of cardiac resynchronization on disease

progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly

symptomatic chronic heart failure. Circulation 2004; 110: 2864-2868. PMID: 15505095

247. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization- Heart Failure (CARE-HF) Study Investigators. The effect of cardiac

resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. PMID: 15753115

248. Salukhe TV, Dimopoulos K, Francis D. Cardiac resynchronisation may reduce all-cause mortality: meta-analysis of preliminary

COMPANION data with CONTAK-CD, InSync ICD, MIRACLE and MUSTIC. Int J Cardiol 2004; 93: 101-103. PMID: 14975534

249. Leclercq C, Cazeau S, Lellouche D, et al. Upgrading from single chamber right ventricular to biventricular pacing in permanently

paced patients with worsening heart failure: The RD-CHF Study. Pacing Clin Electrophysiol 2007; 30: S23-S30. PMID: 17302711

250. Curtis AB, Worley SJ, Adamson PB, et al. Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular

Block (BLOCK HF) Trial Investigators. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;

368: 1585-1593. PMID: 23614585

251. Auricchio A, Metra M, Gasparini M, et al. Multicenter Longitudinal Observational Study (MILOS) Group. Long-term survival of patients

with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy. Am J Cardiol 2007; 99: 232-238.

PMID: 17223424

252. Wilkoff BL, Fauchier L, Stiles MK, et al. Document Reviewers. 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on

optimal implantable cardioverter-defibrillator programming and testing. Europace 2016; 18: 159-183. PMID: 26585598

253. Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-

analysis of randomized controlled trials. Am Heart J 2012; 163: 260-267.e3. PMID: 22305845

254. Beshai JF, Grimm RA, Nagueh SF, et al. RethinQ Study Investigators. Cardiac-resynchronization therapy in heart failure with narrow QRS

complexes. N Engl J Med 2007; 357: 2461-2471. PMID: 17986493

255. Ruschitzka F, Abraham WT, Singh JP, et al. EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS

complex. N Engl J Med 2013; 369: 1395-1405. PMID: 23998714

256. Linde C, Abraham WT, Gold MR, et al. REVERSE (REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction) Study

Group. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with

left ventricular dysfunction and previous heart failure symptoms. JAm Coll Cardiol 2008; 52: 1834-1843. PMID: 19038680

257. Moss AJ, Hall WJ, Cannom DS, et al. MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure

events. N Engl J Med 2009; 361: 1329-1338. PMID: 19723701

258. Tang AS, Wells GA, Talajic M, et al. Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-

resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010; 363: 2385-2395. PMID: 21073365

259. Mullens W, Kepa J, De Vusser P, et al. Importance of adjunctive heart failure optimization immediately after implantation to improve

longterm outcomes with cardiac resynchronization therapy. Am J Cardiol 2011; 108: 409-415. PMID: 21550578

260. Varma N, Epstein AE, Irimpen A, et al. TRUST Investigators. Efficacy and safety of automatic remote monitoring for implantable

cardioverter- defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010; 122: 325-

332. PMID: 20625110

261. Watanabe E, Kasai A, Fujii E, et al. Reliability of implantable cardioverter defibrillator home monitoring in forecasting the need for regular

office visits, and patient perspective. Japanese HOME-ICD study. Circ J 2013; 77: 2704-2711. PMID: 23903000

262. Guédon-Moreau L, Lacroix D, Sadoul N, et al. ECOST trial Investigators. A randomized study of remote follow-up of implantable cardioverter

defibrillators: safety and efficacy report of the ECOST trial. Eur Heart J 2013; 34: 605-614. PMID: 23242192

263. Parthiban N, Esterman A, Mahajan R, et al. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and

Meta-Analysis of Clinical Outcomes. J Am Coll Cardiol 2015; 65:2591-2600. PMID: 25983009

264. Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular

implantable electronic devices. Heart Rhythm 2015; 12: e69-e100. PMID: 25981148

265. Hindricks G, Taborsky M, Glikson M, et al. IN-TIME study group. Implant-based multiparameter telemonitoring of patients with heart

failure (IN-TIME): a randomised controlled trial. Lancet 2014; 384: 583-590. PMID: 25131977

266. Yamada S, Sakakibara M, Yokota T, et al. Acute hemodynamic effects of adaptive servo-ventilation in patients with heart failure. Circ J

2013; 77: 1214-1220. PMID: 23363644

267. Yoshida M, Kadokami T, Momii H, et al. Enhancement of cardiac performance by bilevel positive airway pressure ventilation in heart

failure. J Card Fail 2012; 18: 912-918. PMID: 23207079

268. Ushijima R, Joho S, Akabane T, et al. Differing effects of adaptive servoventilation and continuous positive airway pressure on muscle

sympathetic nerve activity in patients with heart failure. Circ J 2014; 78: 1387-1395. PMID: 24705391

269. Koyama T, Watanabe H, Igarashi G, et al. Short-term prognosis of adaptive servo-ventilation therapy in patients with heart failure. Circ

J 2011; 75: 710-712. PMID: 21266785

270. Momomura S, Seino Y, Kihara Y, et al. SAVIOR-C investigators. Adaptive servo-ventilation therapy for patients with chronic heart

failure in a confirmatory, multicenter, randomized, controlled study. Circ J 2015; 79: 981-990. PMID: 25912560

271. 日本循環器学会，日本心不全学会．心不全におけるASV の適正使用に関するステートメント（第2報）． http://www.j-circ.or.jp/information/

ASV_tekiseiriyou_rep2.pdf

272. Cowie MR, Woehrle H, Wegscheider K, et al. Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. N Engl J

Med 2015; 373: 1095-1105. PMID: 26323938

273. Belardinelli R, Georgiou D, Cianci G, et al. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure:

effects on functional capacity, quality of life, and clinical outcome. Circulation 1999; 99: 1173-1182. PMID: 10069785

274. Stolen KQ, Kemppainen J, Ukkonen H, et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency

in patients with dilated cardiomyopathy. J Am Coll Cardiol 2003; 41: 460-467. PMID: 12575976

275. Coats AJ, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure. Exercise performance,

hemodynamics, ventilation, and autonomic function. Circulation 1992; 85: 2119-2131. PMID: 1591831

276. Piña IL, Apstein CS, Balady GJ, et al. Exercise and heart failure: A statement from the American Heart Association Committee on

exercise, rehabilitation, and prevention. Circulation 2003; 107: 1210- 1225. PMID: 12615804

277. Jetté M, Heller R, Landry F, et al. Randomized 4-week exercise program in patients with impaired left ventricular function. Circulation

1991; 84: 1561-1567. PMID: 1914097

278. Adamopoulos S, Coats AJ, Brunotte F, et al. Physical training improves skeletal muscle metabolism in patients with chronic heart failure.

J Am Coll Cardiol 1993; 21: 1101-1106. PMID: 8459063

279. Hambrecht R, Niebauer J, Fiehn E, et al. Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness

and ultrastructural abnormalities of leg muscles. J Am Coll Cardiol 1995; 25: 1239-1249. PMID: 7722116

280. Belardinelli R, Georgiou D, Scocco V, et al. Low intensity exercise training in patients with chronic heart failure. J Am Coll Cardiol

1995; 26: 975-982. PMID: 7560627

281. Belardinelli R, Georgiou D, Cianci G, et al. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy.

Clinical and prognostic implications. Circulation 1995; 91: 2775-2784. PMID: 7758184

282. Kavanagh T, Myers MG, Baigrie RS, et al. Quality of life and cardiorespiratory function in chronic heart failure: effects of 12 months’

aerobic training. Heart 1996; 76: 42-49. PMID: 8774326

283. Demopoulos L, Bijou R, Fergus I, et al. Exercise training in patients with severe congestive heart failure: enhancing peak aerobic capacity

Cardiol 1997; 29: 597-603. PMID: 9060899

284. Ohtsubo M, Yonezawa K, Nishijima H, et al. Metabolic abnormality of calf skeletal muscle is improved by localised muscle training without

changes in blood flow in chronic heart failure. Heart 1997; 78: 437-443. PMID: 9415000

285. Mancini DM, Henson D, La Manca J, et al. Benefit of selective respiratory muscle training on exercise capacity in patients with chronic

congestive heart failure. Circulation 1995; 91: 320-329. PMID: 7805234

286. Chua TP, Anker SD, Harrington D, et al. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart

failure. Br Heart J 1995; 74: 381-385. PMID: 7488451

287. Kobayashi N, Tsuruya Y, Iwasawa T, et al. Exercise training in patients with chronic heart failure improves endothelial function

predominantly in the trained extremities. Circ J 2003; 67: 505-510. PMID: 12808267

288. Hambrecht R, Fiehn E, Weigl C, et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in

patients with chronic heart failure. Circulation 1998; 98: 2709-2715. PMID: 9851957

289. Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J

Am Coll Cardiol 2005; 45: 1563-1569. PMID: 15893167

290. Adamopoulos S, Parissis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas

ligand system in patients with chronic heart failure. J Am Coll Cardiol 2002; 39: 653-663. PMID: 11849865

291. Oya M, Itoh H, Kato K, et al. Effects of exercise training on the recovery of the autonomic nervous system and exercise capacity after

acute myocardial infarction. Jpn Circ J 1999; 63: 843-848. PMID:10598888

292. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, et al. Effects of exercise rehabilitation program on heart rate recovery in patients with

chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 67-73. PMID: 16449866

293. Adamopoulos S, Ponikowski P, Cerquetani E, et al. Circadian patter n of heart rate variability in chronic heart failure patients. Effects of

physical training. Eur Heart J 1995; 16: 1380-1386. PMID: 8746907

294. Maria Sarullo F, Gristina T, Brusca I, et al. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain

natriuretic peptide levels in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil 2006; 13: 812-817. PMID: 17001223

295. Piepoli MF, Davos C, Francis DP, et al. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart

failure (ExTraMATCH). BMJ 2004; 328: 189-189. PMID: 14729656

296. O’Connor CM, Whellan DJ, Lee KL, et al. HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic

heart failure: HF-ACTION randomized controlled trial. JAMA 2009; 301: 1439-1450. PMID: 19351941

297. Sagar VA, Davies EJ, Briscoe S, et al. Exercise-based rehabilitation for heart failure: systematic review and meta-analysis. Open Heart

2015; 2: e000163. PMID: 25685361

298. Edelmann F, Gelbrich G, Düngen HD, et al. Exercise training improves exercise capacity and diastolic function in patients with heart

failure with preserved ejection fraction: results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol

2011; 58: 1780-1791. PMID: 21996391

299. Nolte K, Herrmann-Lingen C, Wachter R, et al. Effects of exercise training on different quality of life dimensions in heart failure with

preserved ejection fraction: the Ex-DHF-P trial. Eur J Prev Cardiol2015; 22: 582-593. PMID: 24627449

300. Kitzman DW, Brubaker PH, Herrington DM, et al. Effect of endurance exercise training on endothelial function and arterial stiffness in

older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial. J Am Coll Cardiol 2013;

62: 584-592. PMID: 23665370